Liver Retransplantation: The AMC Experience.
- Author:
Sun Hyung JOO
1
;
Sung Gyu LEE
;
Young Joo LEE
;
Kwang Min PARK
;
Shin HWANG
;
Ki Hun KIM
;
Chul Soo AHN
;
Jang Yeong JEON
;
Duk Bok MOON
;
Chong Woo CHU
;
Pyung Chul MIN
Author Information
1. Department of Surgery, Hallym University College of Medicine, Seoul, Korea.
- Publication Type:Original Article
- Keywords:
Liver retransplantation;
Living donor liver transplantation (LDLT)
- MeSH:
Adult;
Allografts;
Aneurysm, False;
Aspergillus;
Cadaver;
Chungcheongnam-do;
Hemorrhage;
Hepatic Artery;
Hospital Mortality;
Humans;
Liver Transplantation;
Liver*;
Living Donors;
Massive Hepatic Necrosis;
Multiple Organ Failure;
Pediatrics;
Pneumonia;
Retrospective Studies;
Rupture;
Transplants
- From:Journal of the Korean Surgical Society
2003;64(6):493-497
- CountryRepublic of Korea
- Language:Korean
-
Abstract:
PURPOSE: Although there has been recent progress in surgical techniques, such as perioperative management, immunosuppresive regimen and intervention radiology, a liver retransplantation remains as the only therapeutic option for patients with a failing liver allograft. The purpose of this study was to review our clinical experiences of liver retransplantation, performed at the Asan Medical Center. METHODS: Between August 1992 and March 2001, 400 cases of liver transplantations, including 331 in adults and 69 in pediatrics, were performed. Of the 331 adult cases, 10 cases of liver retransplantation, during the same period, were retrospectively analyzed. RESULTS: In the 331 cases of adult liver transplantation, 232 cases of living donor and 99 of cadaveric liver transplantations were carried out. The 331 adult cases also included 10 liver retransplantations. Therefore, the overall liver retransplantation rate was 3%. Primary non-function (PNF) was the leading cause of retransplantation. The conversion of living donor liver transplantation to a cadaveric liver retransplantation was the most common type of retransplantaion, with a cadaveric to cadaveric type the second most common. The in-hospital mortality was 40%. The causes of in-hospital mortality were hepatic artery pseudoaneurysm rupture, Aspergillus pneumonia, and multiple organ failure, initiated by jejuno-jejunostomy site bleeding and massive hepatic necrosis. CONCLUSION: In the current era of extreme organ shortage, retransplantation is the only therapeutic alternative for irreVersible graft failure, especially if the patient has no multiple organ failure (MOF) prior to the operation. Therefore, the careful selection of patients for a retransplantation is required. They should be given superurgent priority if the circumstances permit, and living donor liver transplantation (LDLT) offer a promising alternative.
